212 related articles for article (PubMed ID: 27281612)
1. Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells.
Santio NM; Landor SK; Vahtera L; Ylä-Pelto J; Paloniemi E; Imanishi SY; Corthals G; Varjosalo M; Manoharan GB; Uri A; Lendahl U; Sahlgren C; Koskinen PJ
Oncotarget; 2016 Jul; 7(28):43220-43238. PubMed ID: 27281612
[TBL] [Abstract][Full Text] [Related]
2. PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion.
Landor SKJ; Santio NM; Eccleshall WB; Paramonov VM; Gagliani EK; Hall D; Jin SB; Dahlström KM; Salminen TA; Rivero-Müller A; Lendahl U; Kovall RA; Koskinen PJ; Sahlgren C
J Biol Chem; 2021; 296():100593. PubMed ID: 33775697
[TBL] [Abstract][Full Text] [Related]
3. Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts.
Santio NM; Eerola SK; Paatero I; Yli-Kauhaluoma J; Anizon F; Moreau P; Tuomela J; Härkönen P; Koskinen PJ
PLoS One; 2015; 10(6):e0130340. PubMed ID: 26075720
[TBL] [Abstract][Full Text] [Related]
4. PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1.
Mung KL; Eccleshall WB; Santio NM; Rivero-Müller A; Koskinen PJ
Cell Commun Signal; 2021 Jun; 19(1):68. PubMed ID: 34193159
[TBL] [Abstract][Full Text] [Related]
5. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
6. Two novel protein
Takeuchi H; Schneider M; Williamson DB; Ito A; Takeuchi M; Handford PA; Haltiwanger RS
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8395-E8402. PubMed ID: 30127001
[TBL] [Abstract][Full Text] [Related]
7. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
Song JH; Padi SK; Luevano LA; Minden MD; DeAngelo DJ; Hardiman G; Ball LE; Warfel NA; Kraft AS
Oncotarget; 2016 Apr; 7(15):20152-65. PubMed ID: 26956053
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
[TBL] [Abstract][Full Text] [Related]
10. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract][Full Text] [Related]
11. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
Kim SH; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
[TBL] [Abstract][Full Text] [Related]
12. PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins.
Santio NM; Vainio V; Hoikkala T; Mung KL; Lång M; Vahakoski R; Zdrojewska J; Coffey ET; Kremneva E; Rainio EM; Koskinen PJ
Cell Commun Signal; 2020 Aug; 18(1):121. PubMed ID: 32771000
[TBL] [Abstract][Full Text] [Related]
13. The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis.
Liu Z; Brunskill E; Varnum-Finney B; Zhang C; Zhang A; Jay PY; Bernstein I; Morimoto M; Kopan R
Development; 2015 Jul; 142(14):2452-63. PubMed ID: 26062937
[TBL] [Abstract][Full Text] [Related]
14. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
[TBL] [Abstract][Full Text] [Related]
15. The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways.
Santio NM; Salmela M; Arola H; Eerola SK; Heino J; Rainio EM; Koskinen PJ
Exp Cell Res; 2016 Mar; 342(2):113-24. PubMed ID: 26934497
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
Padmanabhan A; Gosc EB; Bieberich CJ
J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
[TBL] [Abstract][Full Text] [Related]
17. Pim family kinases enhance tumor growth of prostate cancer cells.
Chen WW; Chan DC; Donald C; Lilly MB; Kraft AS
Mol Cancer Res; 2005 Aug; 3(8):443-51. PubMed ID: 16123140
[TBL] [Abstract][Full Text] [Related]
18. Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.
Lefort K; Ostano P; Mello-Grand M; Calpini V; Scatolini M; Farsetti A; Dotto GP; Chiorino G
Oncotarget; 2016 Jul; 7(30):48011-48026. PubMed ID: 27384993
[TBL] [Abstract][Full Text] [Related]
19. PIM kinase (and Akt) biology and signaling in tumors.
Warfel NA; Kraft AS
Pharmacol Ther; 2015 Jul; 151():41-9. PubMed ID: 25749412
[TBL] [Abstract][Full Text] [Related]
20. eIF4B phosphorylation by pim kinases plays a critical role in cellular transformation by Abl oncogenes.
Yang J; Wang J; Chen K; Guo G; Xi R; Rothman PB; Whitten D; Zhang L; Huang S; Chen JL
Cancer Res; 2013 Aug; 73(15):4898-908. PubMed ID: 23749639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
